<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T17:59:09Z</responseDate>
  <request identifier="oai:figshare.com:article/34035013" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34035013</identifier>
        <datestamp>2026-09-30T17:30:12Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Serum MDA and GSH levels of mice in the different studied groups on the 19&lt;sup&gt;th&lt;/sup&gt; day PI.&lt;/p&gt;</dc:title>
          <dc:creator>Fadwa M. Arafa (25145191)</dc:creator>
          <dc:creator>Mohamed Hagar (7347941)</dc:creator>
          <dc:creator>Ahmed Zakaria (6164612)</dc:creator>
          <dc:creator>Eman Sheta (12250849)</dc:creator>
          <dc:creator>Nehal N. Hezema (25145194)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>severely deformed ones</dc:subject>
          <dc:subject>scanning electron microscopy</dc:subject>
          <dc:subject>restored villus architecture</dc:subject>
          <dc:subject>new therapeutic avenue</dc:subject>
          <dc:subject>lc – ms</dc:subject>
          <dc:subject>grave risk posed</dc:subject>
          <dc:subject>goblet cell count</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>current research focused</dc:subject>
          <dc:subject>statistically significant rise</dc:subject>
          <dc:subject>serum mda levels</dc:subject>
          <dc:subject>regarding oocyst count</dc:subject>
          <dc:subject>intestinal villi revealed</dc:subject>
          <dc:subject>combating intestinal cryptosporidiosis</dc:subject>
          <dc:subject>similar ultrastructural alterations</dc:subject>
          <dc:subject>bacillus clausii &lt;/</dc:subject>
          <dc:subject>th &lt;/ sup</dc:subject>
          <dc:subject>intestinal cryptosporidiosis</dc:subject>
          <dc:subject>clausii &lt;/</dc:subject>
          <dc:subject>oocyst reduction</dc:subject>
          <dc:subject>mean levels</dc:subject>
          <dc:subject>corresponding rise</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>clausii -&lt;/</dc:subject>
          <dc:subject>vulnerable populations</dc:subject>
          <dc:subject>treated group</dc:subject>
          <dc:subject>synergistic potential</dc:subject>
          <dc:subject>proficient use</dc:subject>
          <dc:subject>mass spectrometry</dc:subject>
          <dc:subject>lymphocytic population</dc:subject>
          <dc:subject>liquid chromatography</dc:subject>
          <dc:subject>incensole isomers</dc:subject>
          <dc:subject>immunosuppressed mice</dc:subject>
          <dc:subject>histopathological findings</dc:subject>
          <dc:subject>highest percentage</dc:subject>
          <dc:subject>extensive pits</dc:subject>
          <dc:subject>either alone</dc:subject>
          <dc:subject>day post</dc:subject>
          <dc:subject>complete distortion</dc:subject>
          <dc:subject>combined therapy</dc:subject>
          <dc:subject>chemical composition</dc:subject>
          <dc:subject>best results</dc:subject>
          <dc:subject>&gt;, ranging</dc:subject>
          <dc:subject>6 %),</dc:subject>
          <dc:description>&lt;p&gt;Serum MDA and GSH levels of mice in the different studied groups on the 19&lt;sup&gt;th&lt;/sup&gt; day PI.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:29:57Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pntd.0014734.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Serum_MDA_and_GSH_levels_of_mice_in_the_different_studied_groups_on_the_19_sup_th_sup_day_PI_p_/34035013</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
